Axa Parenterals Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
as on 18-12-2024
- Paid Up Capital ₹ 7.38 Cr
as on 18-12-2024
- Company Age 19 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 216.17 Cr
as on 18-12-2024
- Satisfied Charges ₹ 455.86 Cr
as on 18-12-2024
- Revenue 12.36%
(FY 2024)
- Profit -0.65%
(FY 2024)
- Ebitda 14.20%
(FY 2024)
- Net Worth 77.06%
(FY 2024)
- Total Assets 45.86%
(FY 2024)
About Axa Parenterals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 7.38 Cr.
The company currently has active open charges totaling ₹216.17 Cr. The company has closed loans amounting to ₹455.86 Cr, as per Ministry of Corporate Affairs (MCA) records.
Puneet Kansal, Sumit Agarwal, Ruchir Gupta, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24232DL2005PLC148247
- Company No.
148247
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Jul 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Axa Parenterals Limited offer?
Axa Parenterals Limited offers a wide range of products and services, including Health Conditions, Respiratory Care.
Who are the key members and board of directors at Axa Parenterals?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Puneet Kansal  | Director | 10-Oct-2005 | Current |
| Sumit Agarwal | Whole-Time Director | 01-Oct-2010 | Current |
| Ruchir Gupta | Whole-Time Director | 01-Oct-2010 | Current |
| Sunil Agarwal | Director | 22-Feb-2019 | Current |
| Vikas Khanna | Director | 16-Aug-2019 | Current |
| Vijaysing Bhandari | Director | 16-Mar-2022 | Current |
Financial Performance and Corporate Structure Insights of Axa Parenterals.
Axa Parenterals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 12.36% increase. The company also saw a slight decrease in profitability, with a 0.65% decrease in profit. The company's net worth Soared by an impressive increase of 77.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Axa Parenterals?
In 2024, Axa Parenterals had a promoter holding of 17.82% and a public holding of 82.18%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Heilsa Life Sciences Private LimitedActive 3 years 2 monthsPuneet Kansal, Sumit Agarwal and 3 more are mutual person
- Humanix Lifesciences Private LimitedActive 8 years 6 months
Sumit Agarwal and Ruchir Gupta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 18 Oct 2024 | ₹3.00 M | Open |
Others Creation Date: 13 Oct 2023 | ₹147.00 Cr | Open |
Hdfc Bank Limited Creation Date: 18 Aug 2023 | ₹2.01 M | Open |
How Many Employees Work at Axa Parenterals?
Axa Parenterals has a workforce of 295 employees as of Dec 18, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Axa Parenterals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axa Parenterals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
